The p53 protein is a central player in cellular response to DNA damage. Induction of p53 by DNA-damaging agents involves elevation of its steady-state level and activation of its potency as a transcription factor. In the cell population, these responses can occur either homogeneously (where every single cell responds simultaneously and similarly to its neighbor) or heterogeneously (where only some cells of a population respond and the number of these increases with increasing dose of inducer). We have studied here the p53 response to DNA-damaging agents (camptothecin, mitomycin C) in individual cells. We show that the level of p53 protein is increased in every single cell of the population homogeneously, while the p53-dependent transcription can be subject to an on/off-type response. Depending on the structure of the target promoter, p53-dependent transcription can be regulated according to the binary or graded model. The on/off-type transcriptional activation pattern of p53 defines two distinct subpopulations of cells after DNA damage.
Introduction
After DNA damage, a living cell acts to ensure errorfree replication and avoid propagation of defective genetic material to daughter cells. Several pathways have been described that participate in maintaining the integrity of genetic material passed to next cell generations. One of them involves tumor-suppressor protein p53 (Wahl and Carr, 2001 ). This protein is an intracellular hub of different signaling pathways (Vogelstein et al., 2000) , which can be induced by DNA damage (Kastan et al., 1991) , oncogenic signaling (Serrano et al., 1997) , hypoxia (Graeber et al., 1994) , ribonucleotide starvation (Linke et al., 1996) and other stress signals.
Induction of p53 involves two types of events. First, its steady-state level in cells increases due to enhanced translation (Fu and Benchimol, 1997) and enhanced stability of the protein (Maltzman and Czyzyk, 1984) . Second, p53 becomes an active transcription factor after post-translational modifications (e.g. phosphorylations and acetylations) (Appella and Anderson, 2001 ). Due to the presence of higher amounts of transcriptionally active p53, the cells start transcribing different p53 target genes, which can lead to either cell cycle block (Kastan et al., 1991; Di Leonardo et al., 1994) or apoptosis (Lowe and Ruley, 1993) . This mechanism typifies the action of p53 as a 'guardian of the genome' (Lane, 1992) , allowing cells to avoid copying damaged DNA. Accordingly, disrupted p53 activity can lead to tumorigenesis: p53 is frequently mutated in human tumors (Hollstein et al., 1994) and p53 knockout mice develop normally, but succumb to tumors (mostly lymphomas) before 6 months of age (Donehower et al., 1992) .
In vivo experiments suggest that transactivation is the main biochemical activity responsible for the tumorsuppressor function of p53 (Chao et al., 2000; Jimenez et al., 2000) , although other activities of p53 have also been described in vitro (Cox et al., 1995; Mummenbrauer et al., 1996; Dudenhoffer et al., 1998) . Many target genes for p53 are known, including its own negative regulator mdm2 (Barak et al., 1993; Perry et al., 1993; Wu et al., 1993) , cdk inhibitor p21/Waf1 (El-Deiry et al., 1993) and apoptosis-inducing proteins PIG3 (Polyak et al., 1997) , PUMA (Nakano and Vousden, 2001; Yu et al., 2001) and NOXA (Oda et al., 2000) . None of such target genes has been found to be exclusively necessary for a particular function of p53, suggesting that p53 performs its function through many target genes in parallel.
In a given cell line, every cell is genetically identical because of their clonal origin. It is therefore widely assumed that, in tissue culture, they all respond to a specific stimulus in similar manner. There are, however, examples of the opposite: an individual cell can respond to a stimulus quite differently from its clonal neighbor (Fiering et al., 1990; Biggar and Crabtree, 2001) .
The extent of cellular p53 response to genotoxic stress in individual cells can be measured using flow cytometry either by staining the cells with fluorescent anti-p53 antibodies (for the level of p53) or registering the expression of green fluorescent protein controlled by p53-dependent promoter (for the transcriptional activity of p53). When every cell reacts similarly to others, the change affects every single cell and the staining intensities of different cells remain narrowly distributed (the corresponding peak at the histogram is narrow) (Figure 1a) . Generation of heterogeneity, however, is manifested by broader staining distribution, changes in the shape of the peak and appearance of multiple peaks. In an ideal situation, the on/off-type regulation generates bimodal distribution of cells (Figure 1b) . In this situation, an individual cell either reacts to the inducer at maximal level (right peak) or there is no reaction at all (left peak).
Here we have studied the induction of p53 after genotoxic stress by camptothecin (cpt) and mitomycin C (MMC) at the single cell level. We show that the increase of p53 steady-state level occurs in all cells uniformly and is higher after more severe doses of stress (graded response model). Transcription from p53-target promoters can follow both graded as well as on/off type of regulation. In the latter case, p53-dependent transcription is activated only in a subset of cells, whereas the number of these increases with increasing dose of chemicals. We conclude that the transcriptional activity of p53 can be regulated as on/off-type response. This on/ off-type transcriptional activation pattern of p53 defines two distinct subpopulations of clonal cells after DNA damage.
Results

p53 protein accumulates uniformly in every cell after genotoxic stress
Accumulation of p53 protein in response to genotoxic stress is a well-established fact (Maltzman and Czyzyk, 1984) . We asked whether similar increase of steady-state p53 level occurs simultaneously in every cell of the population as the dose of stress inducer increases. To answer this question, we treated mouse NIH 3T3 fibroblasts, C7 and B8 cells (derivatives of NIH 3T3, see below) with DNA-damaging drugs camptothecin (cpt) or MMC. The cells were stained with anti-p53 antibodies and analysed by flow cytometry. Figure 2 shows that the increase of p53 level in cells occurs according to the graded response model (Figure 1a) . When the doses of camptothecin or MMC are increased, the peak of cells stained for p53 protein retains the same width and is shifted towards stronger staining. Different cell lines had slightly different sensitivity to the drugs, hence the differences in treatment times. We conclude that these drugs induce the increase of p53 level in every individual cell of the population. Furthermore, this indicates that DNA damage occurs in every cell of the population and all of the cells are able to react to the DNA damage signal.
Only a subset of cells induces transcription from artificial p53-dependent promoter after treatment with cpt or MMC p53 is a transcription factor, which induces transcription from its many target genes containing a proper DNA sequence in their promoters to bind p53. Next we asked how the transcription activation properties of p53 are regulated at the single-cell level. To accomplish this task, For this purpose, we used a fragment of DNA containing p53-binding site from mdm2 gene and TATA box from adenoviral ML promoter (Wu et al., 1993 ) (see also Figure 5a , pmdmAd). This fragment was inserted in front of the EGFP gene and the whole construct was used to produce stable cell lines. When tested in transient transfection, the expression of EGFP was strictly wt p53 dependent (data not shown). C7 and B8 are two different clones expressing EGFP under the control of p53. A similar approach has been used previously to monitor transcription in single cells (Rossi et al., 2000; Biggar and Crabtree, 2001 ). C7 and B8 cells were treated with different concentrations of cpt or MMC (Figure 3a) . The expression of EGFP can be detected only in a subset of cells, yealding the two-peak distribution of cell population. At higher drug concentrations, more individual cells express EGFP. Also, longer treatment of cells with genotoxic drugs leads to higher number of individual cells able to express EGFP (Figure 3a) . At the same time, it is important to mention that longer treatment or higher doses of cpt or MMC do not cause elevation of EGFP expression level in EGFP þ cells: the EGFP þ peaks are with the same intensity both after 1 and 7 mM cpt treatment. When we used a cell line (D2) with the same promoter structure but with different p53-binding site from mouse creatine kinase gene promoter (Lin et al., 1994) , it behaved similarly ( Figure 3a , last column, cell line D2). The drug concentration range, in which the appearance of two peaks is easily detectable, differs slightly in different clones, but the overall pattern of EGFP expression is the same.
EGFP has very long half-life considerably exceeding the length of these experiments (Li et al., 1998) . It is therefore clear that the cells in EGFPÀ population have never expressed it, although the p53 protein is present at high levels in every single cell (see Figure 2 ). This fact is further supported by the experiment, where we analysed both p53 protein level and EGFP expression in the same cells. EGFP expression defines two subpopulations in D2 cells after treatment with MMC ( Figure 3b , left column). When EGFP þ and EGFPÀ cells are gated and analysed separately for their p53 content, both populations exhibit similar, elevated p53 levels ( Figure 3b , right column). We also sorted out EGFP þ and EGFPÀ cells from total population and analysed their p53 content by Western blotting. Compared to untreated cells, p53 levels are elevated in both EGFP þ and EGFPÀ subpopulations of cpt-treated cells ( Figure 3c ). Further evidence comes from the immunofluorescence analysis of B8 cells, which shows that (Figure 7a). These experiments clearly demonstrate that p53 protein levels and its transcriptional activity are regulated separately after the genotoxic stress.
EGFP folds and matures slowly and this probably is the reason why we cannot detect any EGFP signal before 12 h from the beginning of the genotoxic stress (data not shown).
We conclude from these experiments that the transcriptional activity of p53 after genotoxic stress is regulated according to the binary response model in the case of this type of promoter. In an individual cell, p53 transcriptional activity can be either switched on (at maximal level) or off (Rossi et al., 2000; Biggar and Crabtree, 2001 ).
The activation of natural p53 target promoters can exhibit both graded and on/off type behavior More than a hundred p53 target genes are known, each of them having a unique promoter structure. To get insight into how p53 regulates the promoters of its natural target genes, we made cell lines where the expression of EGFP is controlled by Waf1 or PIG3 promoters, both being established as the transcriptional targets of p53 (El-Deiry et al., 1993; Polyak et al., 1997) . In transient transfections, wt p53 was able to induce the EGFP expression from these plasmids (data not shown). Both PIG3 cell lines exhibited the on/off-type transcriptional activation in response to genotoxic stress (Figure 4a ). This indicates that both artificial and natural p53 promoters can respond in a similar way. In contrast, the Waf1 promoter is regulated in graded Alternatively, C7 cells were incubated with 4 mM cpt for 2, 4 or 8 h and harvested after 24 h from the beginning of treatment. (b) D2 cells were treated with MMC for 8 h and after additional 16 h cells were fixed and stained for p53 protein. After the two-color analysis the p53 staining was separately presented for EGFP þ and EGFPÀ cells (right column). n. t. -not treated. min (solid line) and max (dashed line) represent peak values of fluorescence of cells not expressing EGFP or EGFP expression maximum, respectively, or minimal and maximal peak values of p53 protein level (last column). (c) Western blot: B8 cells were incubated with 4 mM cpt for 16 h and EGFP þ and EGFPÀ cells were sorted out using FACS. Cells were counted and lysed for Western blot. n.t. -not treated, GFPÀ -lysate from cells not expressing EGFP, GFP þ -lysate from cells expressing EGFP, not sorted -lysate from total cell population. All lanes contain the lysate from 100 000 cells On/off type p53 transcriptional response A Jõers et al manner after genotoxic stress (Figure 4b ). The cells stain homogeneously for EGFP and the staining intensity is dose-dependent. This shows that at least two types of p53-dependent promoters exist which differ from each other in their regulation pattern (graded or on/off). In order to get mechanistic insight into the on/off versus graded activation of promoters, we made several constructs where elements from artificial (on/off responder) and Waf1 (graded responder) promoters were combined. Waf1 promoter contains at least two p53 binding sites to which p53 protein can bind in vivo (Espinosa and Emerson, 2001 ). We inserted both of these in front of the artificial basal promoter and combined Waf1 basal promoter with p53-binding sites from mdm2 promoter (Figure 5a ). In this way, we could test the sequence elements from Waf1 promoter separately. All promoter constructs were inserted in front of the EGFP gene and we used them to create stable cell lines (using NIH 3T3 cells). At least four independent clones with each construct were analysed after treatment with cpt and the results from representative cell lines are shown in Figure 5b . All the three cell lines, containing different element from Waf1 promoter in their reporter constructs, behaved in an on/off manner after genotoxic stress. This indicates that none of the sequence elements analysed is able to ensure the graded response.
Endogeneous target genes of p53 can also be induced either gradually or binary manner
The transcriptional activity of p53 leads to the elevation of the protein levels of its target genes. To follow the expression pattern of endogenous Waf1 and mdm2 proteins, we induced the genotoxic stress with cpt or MMC in different cell lines and stained the cells for these proteins with appropriate antibodies. In ArfÀ/À MEF (data not shown) and NIH 3T3 cell lines, both Waf1 and mdm2 proteins followed the gradual model of induction (Figure 6a ). This result is in good correlation with GFP experiments, as the reporter construct with Waf1 endogenous promoter in NIH 3T3-based cell line also exhibited gradual behavior. In contrast, in response to MMC treatment, endogeneous Waf1 is induced in an on/off manner in MCF7 cells (Figure 6c ), while p53 protein accumulates homogenously (Figure 6b ). There are two populations already in untreated cells and induction of Waf1 clearly follows the binary model. This finding was confirmed by immunofluorescence data, where p53 can readily be detected after MMC treatment in all the nuclei, but p21 expression is visible in a subset of cells (Figure 7b ). Subsequently, we created a stable cell line using MCF7 cells and Waf1 promoter in front of the EGFP gene (clone (Figure 8a ). During this time, however, increasing amount of cells become EGFP þ (data not shown). This result shows that EGFP (and therefore activity of p53) can be induced at any phase of the cell cycle.
When cpt is removed from the cells after 12 h of treatment, the EGFPÀ and EGFP þ subpopulations behave differently. EGFPÀ cells transiently accumulate in S and G 2 (Figure 8b ) and then restore their normal cell cycle profile. The EGFP þ cells, however, become arrested in G 2 /M. This clearly demonstrates that after treatment of clonal cells with DNA-damaging agents the transcriptional activity of p53 determines two subpopulations of cells with different fate: the ones who succeed to activate their p53 get arrested in G 2 /M, whereas the others return to the cell cycle.
The ability to activate/not activate the p53-dependent transcription is not inherited in on/off responder cell lines Despite their clonal origin, the cells from the same cell line could accumulate genetic and/or epigenetic changes that could make them respond differently after genotoxic stress. To analyse this, we induced the C7 cell line with 1 mM cpt, that leads to the two-peak distribution of EGFP signal in this cell line. We used the cell sorter to sort out both EGFP þ and EGFPÀ cells (Figure 9, top  panel) . After separated regrowth, we analysed both populations for their responsiveness to cpt treatment. As shown in Figure 9 , both sorted populations exhibited very similar behaviour -they responded in an on/off manner with similar sensitivity to the cpt. Analogous experiment with PIG A8 cell line gave the same result (data not shown). This demonstrates that the decision to activate/not activate transcription from promoter after the first treatment with cpt does not influence the same decision after the second treatment.
Discussion
Although identical in their genetic background and growth conditions, individual cells of a clonal cell population can still behave differently in response to the same stimulus. In this paper, we describe the p53 response to genotoxic stress in individual cells. We show that the steady-state level of p53 protein is increased in every single cell of the population shortly after addition of the DNA-damaging agent. Transactivation from Waf1 promoter in NIH 3T3 cells is also uniform; however, only a subpopulation of cells succeeds in p53-dependent transactivation if different p53 target promoters are used. This generates two subpopulations among genetically homogenous cells. Therefore, the transcriptional activation of p53 protein can act like an on/off switch.
What can be the mechanism of the on/off transcriptional activation response? The two models -graded versus binary -have been studied earlier in other systems. Fiering et al., 1990 have demonstrated that after stimulation of TCR pathway in Jurkat T cells the NF-AT and NF-kB-dependent transcription is regulated by an on/off pattern. In yeast cells, the GAL4-dependent transcription from GAL1 promoter occurring in response to changes in sugar composition of the growth medium is also regulated by binary mode (Biggar and Crabtree, 2001 ). These studies, however, did not address the expression pattern of the transcrip- 3 and 7) and, therefore, this possibility is excluded. It has been shown that the same promoter can be regulated in either a graded or binary manner. Artificial tet-dependent promoter responds gradually to altered activity of either tet-activator or tet-repressor (Rossi et al., 2000) . However, when both modulators are coexpressed, the transactivation is regulated in a binary manner. In this example, doxycyclin controls the DNAbinding activity of both the activator and repressor in opposite ways and the binary regulation is apparently achieved due to their highly cooperative binding to the multiple binding sites in the promoter. In our experiments, the full-length Waf1 promoter in NIH 3T3 cells is regulated by graded model, but artificial promoters, containing the same p53 binding sites, show binary behavior ( Figure 5 ). This suggests that some other DNA element, or a combination of these, is responsible for determining the response mode. However, the same fulllength Waf1 promoter behaved by an on/off model in MCF7 cell line. This indicates the need for some transfactor to specify the activation mode. As many different promoter settings all behaved in an on/off manner, it is reasonable to suggest that a special determinant is needed for gradual response -an open chromatin structure, for example.
p53 might need a specific modification for transactivation initiation from PIG3, but not from Waf1 promoter. Indeed, serine-18 (equivalent to human serine-15) phosphorylation displays heterogeneity among induced cells, but this does not correlate with EGFP staining (data not shown). It still may be that p53 acquires a specific modification needed for transactivation from PIG3 promoter in only a subset of cells. Indeed, PIG3 and Waf1 promoters have different requirements for p53 activity as the p53 lacking the proline-rich domain can activate transcription from the Waf1 promoter but not from the PIG3 promoter (Venot et al., 1998) .
A stochastic variation could explain the different gene expression of EGFP þ and EGFPÀ cells, which are identical before genotoxic stress. Stochastic variation in gene expression has been described in both prokaryotic (Elowitz et al., 2002) and eukaryotic (Graubert et al., 1998; de Krom et al., 2002) cells and it can lead to the prolonged bistable expression states (Blake et al., 2003) . On the assumption that the cells are not predetermined to react to DNA damage the way they do, the stochastic step must take place between the DNA damage and the cell decision to express or not to express EGFP. The result of our cell-sorting experiment (Figure 9 ) supports the idea that cells are not predetermined and the choice to start the EGFP expression is probabilistic.
The on/off regulation of p53-dependent transcription creates the situation, where there are always cells in a population, which have no fully activated p53 response after treatment with genotoxic agent. These cells are to some extent functionally 'p53-negative' and in danger to accumulate mutations. Thus, some cells do not react to DNA damage 'properly' even before the mutations in Figure 9 EGFP induction dynamics is not influenced by the cell behavior in the previous induction. C7 cells were treated with 1 mM cpt for 4 h and analysed after 24 h (first induction). EGFPÀ and EGFP þ cells were sorted into separate pools. After growing up, the originally different subpopulations were subjected again to the cpt treatment (second induction). The doses are indicated on the panels, the treatment lasted for 4 h and cells were analysed after 24 h. n. t. -not treated. min (solid line) and max (dashed line) represent peak values of fluorescence of cells not expressing EGFP or EGFP expression maximum respectively their DNA have occurred: the sensitivity of activation of the p53-dependent pathway seems to be insufficient to ensure transcriptional activation of p53 in every single cell. However, recent evidence suggests that there is a trade-off between processes avoiding the cancer and aging (Sharpless and DePinho, 2002; Tyner et al., 2002) . It therefore seems that the sensitivity of p53 activation is finetuned by evolution and represents the optimal balance.
Materials and methods
Plasmids and cell lines
For p53-dependent EGFP reporters, we substituted the CMV promoter in pEGFP N1 (Clontech) with a 2.4 kb. fragment from the human Waf1 promoter (WAF cell lines) or with a 2.6 kb fragment from the Pig3 promoter (PIG cell lines). We used these constructs to stably transfect NIH 3T3 or MCF7 cells. Individual genetecin-resistant colonies were picked for further analysis. A very similar construct, where EGFP was substituted with farnesylated EGFP (Clontech), was used to generate C7 and B8 cell lines; the CMV promoter in pEGFP N1 in this case was substituted with an artificial p53-dependent promoter from pBP100 (Wu et al., 1993) resulting in the plasmid pmdmAd.
The p53-binding site from mdm2 promoter in pmdmAd was replaced with either À2.3 or À1.4 kb p53-binding site from human Waf1 promoter (Espinosa and Emerson, 2001 ) resulting in p2.3Ad and p1.4Ad, respectively. pmdmW was obtained by substituting the artificial basal promoter in pmdmAd with a basal promoter of human Waf1. All constructs were verified by sequencing and they were used to generate the stable cell lines. NIH 3T3 and MCF7 cells were maintained in IMDM with 10% FCS at 371C, 5% CO 2 . In the case of stable cell lines, also geneticin (Gibco) to a final concentration of 0.3 mg/ml (for NIH 3T3) or 0.5 mg/ml (for MCF7) was added.
Immunostaining for flow cytometry
Cells were collected, washed with PBS and resuspended in 500 ml of 4% paraformaldehyde in PBS for fixing. After 15 min at room temperature, 5 ml of 1% BSA in PBS-Tween (BPT) was added, followed by centrifugation at 300g for 5 min. Cells were resuspended in 0.2% Triton X-100 in PBS and incubated for 10 min on ice. After addition of 5 ml of BPT and centrifugation, the cells were incubated in primary antibody solution in 5% nonfat dry milk in PBS-Tween (0.05%). We used PAb 122, PAb 200 and PAb 240 for p53 protein detection, monoclonal anti-mdm2 antibody (2A10) and polyclonal anti-p21/Waf1 antibody (Abcam). All antibody incubations were done in room temperature for 1 h. The cells were washed once with 5 ml BPT and incubated with the appropriate secondary antibody in BPT. After washing, the cells were analysed in FacsCalibur (BD Biosystems).
Western blot
Cell lysates were separated in 10% polyacrylamide gel electrophoresis and transferred to PVDF membrane. After blocking with 5% nonfat dry milk in PBS-Tween (0.05%), we incubated the membrane with anti-p53 monoclonal antibodies PAb 122, PAb 200 and PAb 240. Sheep anti-mouse biotinylated antibody was used as the secondary antibody, followed by streptavidin-alkaline phosphatase conjugate. p53 was visualized using NBT and BCIP as substrates.
Immunofluorescence analysis
Cells were grown on the coverslips and treated as indicated in the figure legend. Cells were fixed with 4% paraformaldehyde in PBS for 15 min at room temperature and permeabilized with 0.2% Triton X-100 in PBS for 10 min on ice. p53 protein was detected using monoclonal antibodies PAb240 and PAb122 and anti-mouse secondary antibody conjugated with Alexa Fluor 594 (Molecular Probes). p21 protein was visualized using rabbit polyclonal antibody (Abcam) and FITC-conjugated anti-rabbit secondary antibody (Abcam). The images were obtained using Olympus BX41 microscope coupled with Olympus DX70 CCD camera using standard filtersets.
Cell cycle analysis
Cells were collected and resuspended in 100 ml of ice-cold PBS, followed by addition of 1 ml of ice-cold ethanol. Cells were kept on ice for 5 min and rehydrated by adding 5 ml of BPT. After centrifugation (300g, 10 min), cells were resuspended in PBS containing 1 mM MgCl 2 and 100 mg/ml RNase A. Incubation on ice took 15 min, then propidium iodide was added to the final concentration of 10 mg/ml, cells were kept in dark for additional 20 min and analysed in FacsCalibur (BD Biosystems).
